JPS57131725A - Remedy for immune complex disease - Google Patents
Remedy for immune complex diseaseInfo
- Publication number
- JPS57131725A JPS57131725A JP56018429A JP1842981A JPS57131725A JP S57131725 A JPS57131725 A JP S57131725A JP 56018429 A JP56018429 A JP 56018429A JP 1842981 A JP1842981 A JP 1842981A JP S57131725 A JPS57131725 A JP S57131725A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- remedy
- human urine
- acid protease
- buffer solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000024781 Immune Complex disease Diseases 0.000 title abstract 2
- 208000024326 hypersensitivity reaction type III disease Diseases 0.000 title 1
- 208000025883 type III hypersensitivity disease Diseases 0.000 title 1
- 108091005508 Acid proteases Proteins 0.000 abstract 3
- 210000002700 urine Anatomy 0.000 abstract 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 abstract 1
- 208000005777 Lupus Nephritis Diseases 0.000 abstract 1
- 239000006096 absorbing agent Substances 0.000 abstract 1
- 239000008351 acetate buffer Substances 0.000 abstract 1
- 239000007853 buffer solution Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000005227 gel permeation chromatography Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000002504 physiological saline solution Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000006215 rectal suppository Substances 0.000 abstract 1
- 229940100618 rectal suppository Drugs 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56018429A JPS57131725A (en) | 1981-02-10 | 1981-02-10 | Remedy for immune complex disease |
| CA000395742A CA1181005A (en) | 1981-02-10 | 1982-02-08 | Therapeutic agent for treatment of allergic diseases, immune complex diseases and tumors |
| AU80290/82A AU531314B2 (en) | 1981-02-10 | 1982-02-09 | Therapeutic agent containing human urinary acid protease |
| CH782/82A CH653557A5 (de) | 1981-02-10 | 1982-02-09 | Zur behandlung von allergischen zustaenden, immunkomplexkrankheiten und tumoren geeignetes therapeutisches mittel. |
| GB8203682A GB2095993B (en) | 1981-02-10 | 1982-02-09 | Compositions containing human urinary acid protease |
| SE8200748A SE455163B (sv) | 1981-02-10 | 1982-02-09 | Uropepsin for anvendning som terapeutikum mot allergiska sjukdomar, immunkomplexsjukdomar och tumorer |
| EP82100973A EP0059346B1 (en) | 1981-02-10 | 1982-02-10 | Therapeutic agent containing a human urinary pepsin |
| FR8202145A FR2499409A1 (fr) | 1981-02-10 | 1982-02-10 | Agent therapeutique a base d'une protease acide, pour le traitement des troubles allergiques, des maladies avec immunocomplexe et des tumeurs |
| DE19823204631 DE3204631A1 (de) | 1981-02-10 | 1982-02-10 | Therapeutisches mittel und dessen verwendung |
| NL8200509A NL8200509A (nl) | 1981-02-10 | 1982-02-10 | Geneesmiddel voor allergiekwalen, immuuncomplexziekten en tumoren; werkwijze voor het behandelen van patienten die hieraan lijden. |
| DE8282100973T DE3273953D1 (en) | 1981-02-10 | 1982-02-10 | Therapeutic agent containing a human urinary pepsin |
| IT47761/82A IT1154280B (it) | 1981-02-10 | 1982-02-10 | Agente terapeutico a base di protea si acida e suo impiego in pazienti affetti da disordini allergici,malattie da immuno-complessi e tumori |
| US06/365,465 US4540569A (en) | 1981-02-10 | 1982-04-05 | Method for treatment of allergic disorders and immune complex diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56018429A JPS57131725A (en) | 1981-02-10 | 1981-02-10 | Remedy for immune complex disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57131725A true JPS57131725A (en) | 1982-08-14 |
| JPS6237611B2 JPS6237611B2 (2) | 1987-08-13 |
Family
ID=11971396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56018429A Granted JPS57131725A (en) | 1981-02-10 | 1981-02-10 | Remedy for immune complex disease |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS57131725A (2) |
-
1981
- 1981-02-10 JP JP56018429A patent/JPS57131725A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6237611B2 (2) | 1987-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Brade et al. | Ifosfamide-pharmacology, safety and therapeutic potential | |
| GR76810B (2) | ||
| JPS5756427A (en) | Medicine containing 2-phenyl-1,2-benzisoselenazole- 3(2h)-one | |
| LTIP1751A (en) | Oral composition for the treatment of inflammatory bowel diseases | |
| BG60253B1 (bg) | Човешки тъканен плазминогенен активатор | |
| JPS5535049A (en) | Amino acid transfusion for cancerous patient | |
| DE3279946D1 (en) | Rectally administrable suppository comprising a drug and an adjuvant | |
| Gray et al. | Protective effect of pitressin and epinephrine against total body X-irradiation | |
| ES8504459A1 (es) | Procedimiento para preparar factor de transferencia especifico a un virus determinado. | |
| JPS56138111A (en) | Suppository containing unsaturated fatty acid or salt thereof | |
| GB2092001B (en) | Pharmaceutical preparations comprising sodium fructose-1,6-diphosposphate for treatment of burn patients | |
| BG96324A (bg) | Фармакологично активно вещество врс, метод за неговото получаване и терапевтичното му приложение | |
| IE44814L (en) | Treatment of gastroenteritis. | |
| Hamaoka et al. | Antibody production in mice: II. The mechanism of antigenic stimulation in the secondary immune response | |
| JPS56138110A (en) | Suppository containing citric acid or salt thereof | |
| JPS5557520A (en) | Preparation of carcinostatic substance | |
| JPS56138112A (en) | Suppository containing ascorbic acid or sodium ascorbate | |
| JPS55113721A (en) | Immunity regulator | |
| JPS5543041A (en) | Immunity raising agent | |
| Snyder et al. | Effect of Escherichia coli Alpha-Hemolysin on Human Peripheral Leukocyte Viability In Vitro. | |
| JPS56138115A (en) | Suppository containing acidic amino acid or derivative thereof | |
| Drozdovskiĭ et al. | Radiosynoviorthese in the treatment of patients with rheumatoid arthritis | |
| Ling | The association-induction hypothesis. A theoretical foundation provided for the possible beneficial effects of a low Na, high K diet and other similar regimens in the treatment of patients suffering from debilitating illnesses | |
| JPS5599191A (en) | Purification of kallikrein in human urine | |
| JPS57203013A (en) | Remedy for viral hepatitis of oral agent type |